Table 2.
List of top variants annotated to the five presynaptic assembly genes enriched in the European GWAS of BIS in JME (n = 324).
Gene | Location | Size | rsid | Beta | P value | PVE |
---|---|---|---|---|---|---|
PTPRD | chr9:8,314,246–10,613,002 | 2,298,757 | rs1781264 | 1.827 | 1.19E-04 | 0.042 |
NLGN1 | chr3:173,398,448–174,286,644 | 888,197 | rs73177088 | 6.191 | 9.95E-04 | 0.044 |
NLGN4X | chrX:5,890,042–6,228,867 | 338,826 | rs146813567 | −2.898 | 3.06E-04 | 0.039 |
IL1RAPL1 | chrX:28,587,446–29,956,718 | 1,369,273 | rs5943492 | 1.039 | 8.73E-04 | 0.043 |
PTEN | chr10:87,862,563–87,971,930 | 109,368 | rs112050451 | 5.158 | 1.27E-03 | 0.041 |
Variants with P ≤ 5 × 10−4 were annotated to the gene with the nearest transcription start site using the Ensembl Variant Effect Predictor (v94)62. This gene set was used as input in a GO enrichment analysis63,64, to test for enrichment in annotated pathways. One-sided hypergeometric tests were completed to identify over-representation of pathways42. To reduce the risk of false positive results, a permutation procedure65 was employed by randomly shuffling GWAS p values 2000 times, each time re-applying the P ≤ 5 × 10−4 threshold and calculating the hypergeometric test statistics. For each pathway, the final permutation-based p value was calculated as the percentage of the 2000 permutations that produced a p value less than or equal to the p value calculated from the non-permuted data. A pseudo count was added during this calculation to prevent calculating p values equal to 0.
PTPRD, Protein Tyrosine Phosphatase Receptor Type D; NLGN1, Neuroligin 1; NLGN4X, Neuroligin 4 X-Linked; IL1RAPL1, Interleukin 1 Receptor Accessory Protein Like 1; PTEN, Phosphatase and Tensin Homologue.